United States· US:71610-871_29b8f9fb-7384-9fd4-e063-6394a90ad5d9
Pregabalin
A pregabalin product containing pregabalin, registered in United States by Aphena Pharma Solutions - Tennessee, LLC. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Pregabalin is registered in 16 of 19 countries.
Countries holding a registration under ATC N02BF02 (pregabalin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Pregabalin · ATC N02BF02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pregabalin costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.25 in United States to $2.99 in Switzerland — a ×12 gap.
- United States: $0.25 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Pregabalin · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.99
- IT Italy$1.59
- US United States$0.25 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PREGABALIN
- Manufacturer
- Aphena Pharma Solutions - Tennessee, LLC
- Country
- United States (US)
- ATC code
- N02BF02
- ATC class
- Pregabalin
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc11716108713030 CAPSULE in 1 BOTTLE (71610-871-30)
- ndc11716108714656 CAPSULE in 1 BOTTLE (71610-871-46)
- ndc11716108715360 CAPSULE in 1 BOTTLE (71610-871-53)
- ndc117161087192270 CAPSULE in 1 BOTTLE (71610-871-92)
- ndc1171610-871-30
- ndc1171610-871-46
- ndc1171610-871-53
- ndc1171610-871-92
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
244 interactions on record for pregabalin.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pregabalin · interactions on record
244 records
- 4 severe
- 60 moderate
- 180 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pregabalin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLYRICAUpjohn EESV, Capelle aan den IJssel
- United KingdomAlzain 100mg capsulesDr Reddy's Laboratories (UK) Ltd
- SpainGATICA 100 MG CAPSULAS DURAS EFGLaboratorios Alter S.A.
- SwedenBrieka 100 mg Kapsel, hårdTeva B.V.
- FranceLYRICA 100 mg, géluleUPJOHN (PAYS-BAS)
- FinlandBriekaActavis Group PTC ehf
- NetherlandsLinefor 100 mg, harde capsulesPharmaceutical Works Polpharma S.A.
- IrelandLyrica 100 mg hard capsulesUpjohn EESV
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Lynagex, Lynagex 165 Mg
- Belgium · Lynagex, Pregabalin Ab
- Bulgaria · Pregabin, Бриека
- Cyprus · Epibal, Grabilen
- Czechia · Kartesada, Naxalgan
- Germany · Pregabador, Pregabahexal
- Denmark · Galberin, Lyribastad
- Estonia · Brieka, Bulgaplin
- Spain · Aciryl, Apregia
- Finland · Lyribastad, Pregabalin Grindeks
- France · Lexenu, Lexenu 75 Mg
- United Kingdom (Northern Ireland) · Alzain, Avellar
- Greece · Algecia, Apregalin
- Croatia · Pragiola, Pregabalin Belupo
- Hungary · Kartesada, Naxalgan
- Ireland · Pregabalin Basics, Pregabalin Brillpharma (Ireland)
- Iceland · Brieka, Lyrica
- Italy · Aclaton, Ecubalin
- Liechtenstein · Lyrica, Pregabalin Accord
- Lithuania · Brieka, Bulgaplin
- Luxembourg · Pregabalin Micro Labs, Pregabaline Eg
- Latvia · Brieka, Bulgaplin
- Malta · Epibal, Pragiola
- Netherlands · Dalingo, Linefor
- Norway · Lyrica, Pregabalin 1a Farma
- Poland · Bulgaplin, Egzysta
- Portugal · Kartesada, Lygabrin
- Romania · Lynagex, Pragiola
- Sweden · Brieka, Bulgaplin
- Slovenia · Pragiola, Pregabalin Grindeks
- Slovakia · Kartesada, Naxalgan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c4cbfd2a-58e1-4d0a-aa06-02bb885c2c55 GET /v1/drugs/c4cbfd2a-58e1-4d0a-aa06-02bb885c2c55?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "PREGABALIN",
"productndc": "71610-871",
"dosage_form": "CAPSULE",
"dea_schedule": "CV",
"strength_unit": "mg/1",
"application_number": "ANDA205321",
"marketing_category": "ANDA"
}See everything about pregabalin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.